Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.17 0.00 (-0.42%)
As of: Oct 21, 2026 · 3:30 PM EDT

Chemomab Therapeutics (CMMB) Interest Coverage Ratio (2011 - 2019)

Updated

Chemomab Therapeutics' (CMMB) Interest Coverage Ratio was 6.93 for Q4 2023, down 66.6% from 20.74 a year earlier and down 59.0% from the prior quarter.

Analysis

Chemomab Therapeutics (CMMB) Interest Coverage Ratio (2011 - 2019) Analysis & Trends

For FY2023, Interest Coverage Ratio at Chemomab Therapeutics was 18.56, down 76.4% from FY2022.

  • By year, Interest Coverage Ratio came in at 78.83 in FY2022 (-30.5%), 113.41 in FY2021 and 3014.78 in FY2019.
  • The Q4 2023 figure ranks as the lowest quarterly Interest Coverage Ratio since Q3 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn -
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn 25.41
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn -
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn -
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn 10.28
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 7.27
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn -42.08
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn -
10 Chemomab Therapeutics 7.49 Mn -27.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 -1.41
Sep 30, 2019 0.16
Jun 30, 2019 1.61
Mar 31, 2019 0.42
Dec 31, 2018 7.22
Sep 30, 2018 18.98
Jun 30, 2018 2.58
Mar 31, 2018 44.75
Dec 31, 2012 1.44
Sep 30, 2012 17.71
Jun 30, 2012 1.41
Dec 31, 2011 1.77
Sep 30, 2011 10.69
Jun 30, 2011 2.76
API Access

Chemomab Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=CMMB&period=max&api_key=YOUR_API_KEY